港股市场速览：全风格均衡上涨，创新药板块领先

Investment Rating - The report maintains an "Outperform" rating for the Hong Kong stock market [4] Core Insights - The Hong Kong stock market has shown a balanced increase across all styles, with the innovative drug sector leading the gains [1] - The Hang Seng Index increased by 1.3%, with the Hang Seng Composite Index also rising by 1.3% [1] - The report highlights a significant divergence in performance among major concept indices, with the Hang Seng Biotechnology Index rising by 7.0% and the Hang Seng Internet Index declining by 2.0% [1] Summary by Sections Market Performance - The Hang Seng Index's valuation increased by 1.1% to 12.2x, while the Hang Seng Composite Index's valuation rose by 1.3% to 12.1x [2] - The report notes that 20 industries saw an increase in valuation, with notable rises in Steel (+14.0%), Agriculture (+7.4%), Real Estate (+6.8%), and Pharmaceuticals (+6.2%) [2] Earnings Expectations - The earnings per share (EPS) for the Hang Seng Index increased by 0.4% compared to the previous week [3] - The report indicates that 18 industries experienced upward revisions in EPS, with the most significant increases in Electric Power Equipment and New Energy (+4.3%) and Construction (+1.8%) [3]